Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Biogen Inc (NASDAQ:BIIB)

304.21
Delayed Data
As of Sep 02
 +11.71 / +4.00%
Today’s Change
265.00
Today|||52-Week Range
480.18
-10.38%
Year-to-Date

Today’s Trading

Previous close292.50
Today’s open298.48
Day’s range293.61 - 304.43
Volume2,271,640
Average volume (3 months)2,373,252
Market cap$68.8B
Dividend yield--
Data as of 09/02/2015

Growth & Valuation

Earnings growth (last year)+58.39%
Earnings growth (this year)+15.04%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)+39.61%
P/E ratio20.6
Price/Sales8.30
Price/Book6.35

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen+4.83+3.28%
BXLTBaxalta Inc+0.35+1.01%
BAXBaxter International...+0.17+0.46%
XONIntrexon Corp+1.23+2.94%
Data as of 09/02/2015

Financials

Next reporting dateOctober 27, 2015
EPS forecast (this quarter)$3.91
Annual revenue (last year)$9.7B
Annual profit (last year)$2.9B
Net profit margin30.27%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer
George A. Scangos
Chief Financial Officer &
Executive Vice President
Paul J. Clancy
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers